Sei Investments Co. Purchases 721,947 Shares of Infosys Limited (NYSE:INFY)

Sei Investments Co. boosted its position in Infosys Limited (NYSE:INFY) by 94.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,482,644 shares of the technology company’s stock after purchasing an additional 721,947 shares during the quarter. Sei Investments Co.’s holdings in Infosys were worth $32,499,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Bank Julius Baer & Co. Ltd Zurich boosted its position in shares of Infosys by 1,668.3% in the fourth quarter. Bank Julius Baer & Co. Ltd Zurich now owns 3,228,211 shares of the technology company’s stock valued at $75,470,000 after acquiring an additional 3,045,656 shares during the period. Public Employees Retirement System of Ohio bought a new stake in Infosys in the 3rd quarter valued at about $36,039,000. Robeco Institutional Asset Management B.V. grew its position in shares of Infosys by 6.2% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 25,841,022 shares of the technology company’s stock worth $566,435,000 after purchasing an additional 1,501,039 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. increased its holdings in shares of Infosys by 1,606.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 1,454,437 shares of the technology company’s stock worth $32,143,000 after purchasing an additional 1,369,210 shares during the period. Finally, American Century Companies Inc. raised its position in shares of Infosys by 31.3% in the fourth quarter. American Century Companies Inc. now owns 4,603,993 shares of the technology company’s stock valued at $100,920,000 after buying an additional 1,097,105 shares in the last quarter. 16.20% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages recently issued reports on INFY. StockNews.com downgraded Infosys from a “buy” rating to a “hold” rating in a research report on Thursday, March 20th. CLSA raised Infosys from a “hold” rating to an “outperform” rating in a report on Friday, March 7th. Hsbc Global Res raised Infosys from a “hold” rating to a “strong-buy” rating in a research note on Monday, December 9th. Guggenheim reaffirmed a “neutral” rating on shares of Infosys in a research report on Friday, January 17th. Finally, HSBC raised shares of Infosys from a “hold” rating to a “buy” rating in a report on Monday, December 9th. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $19.70.

Infosys Trading Up 1.5 %

INFY stock opened at $18.86 on Wednesday. The firm has a 50-day moving average price of $20.66 and a 200-day moving average price of $21.84. Infosys Limited has a 12 month low of $16.04 and a 12 month high of $23.81. The stock has a market capitalization of $78.12 billion, a P/E ratio of 23.87, a price-to-earnings-growth ratio of 3.50 and a beta of 1.01.

Infosys (NYSE:INFY) last issued its quarterly earnings data on Thursday, January 16th. The technology company reported $0.19 EPS for the quarter, meeting the consensus estimate of $0.19. Infosys had a net margin of 17.28% and a return on equity of 31.60%. During the same period in the prior year, the business posted $0.18 earnings per share. As a group, equities analysts predict that Infosys Limited will post 0.74 EPS for the current fiscal year.

About Infosys

Infosys Ltd. is a digital services and consulting company, which engages in the provision of end-to-end business solutions. It operates through the following segments: Financial Services, Retail, Communication, Energy, Utilities, Resources, and Services, Manufacturing, Hi-Tech, Life Sciences, and All Other.